On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Completes Majority Acquisition of Plant-Based CBD Skincare Brand

  • GLDFF closes on majority ownership of Fifth & Root Inc.
  • The acquisition of these distribution channels “greatly increases the company’s visibility and reach,” says CEO
  • Fifth & Root brand are ideal match for Golden Leaf and its commitment to produce variety of products for new users as well as seasoned customers
In another move designed to advance its Crawl, Walk, Run strategy, Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF) has announced the closing of its previously announced majority ownership purchase of Fifth & Root Inc., a nationally recognized CBD skincare brand based in California (https://ibn.fm/iOdyV). Golden Leaf is a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution of high-quality cannabis. “The acquisition of these distribution channels greatly increases the company’s visibility and reach, and continues to advance our Crawl, Walk, Run strategic approach,” said Golden Leaf CEO Jeff Yapp. “As we look forward to the eventual federal legalization of cannabis, Fifth & Root’s commerce platform and partnerships will position the company favorably to capitalize on the evolving marketplace. Fifth & Root, a leader in CBD beauty, offers an exceptional line of clean and innovative products. We’re thrilled to add them to Golden Leaf Holdings’ portfolio of products and look forward to growing this brand within the burgeoning CBD skin-care space.” Designed with a “GenZennial” customer in mind, the Fifth & Root brand is an ideal match for Golden Leaf and its commitment to produce a variety of products for new users as well as seasoned customers for both medical and recreational use, with a focus on optimal health and wellness. Fifth and Root was formulated and designed to capture the “vibe of the innovative and experiential formulas in both branding and packaging,” observed Leilah Mundt, founder of beauty branding and sales agency Crème Collective, which worked on the branding for the line. “The formulas are bright and alive with sophisticated terpene blends that smell incredible, as well as being a proven delivery system for the active ingredients. Our goal was to mirror this in all brand touch points.” Fifth & Root is distinctive in that it is a women-founded company; in addition, its products are created and developed by women scientists and herbalists. From the beginning, the vision was to bring transformative, spell-binding skin care to consumers. The line offers powerful, effective formulations that omit toxins and irritants, including toxic chemicals, synthetics, GMOs, parabens, phthalates, harsh preservatives, skin-stripping sulfates and animal byproducts. Fifth & Root products—there are currently six—are sold in more than 425 retail locations, including national retailers such as Ulta Beauty, Nordstrom, Urban Outfitters, Anthropologie, Revolve and more. In addition, it can be purchased online (https://ibn.fm/xuwJ0). Golden Leaf Holdings is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with seven dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. Markets served include Oregon, California, Nevada, and Washington. For more information, visit the company’s website at www.GoldenLeafHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to GLDFF are available in the company’s newsroom at https://ibn.fm/GLDFF

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.